Efficacy of olanzapine monotherapy in acute bipolar depression: A pooled analysis of controlled studies

Journal of Affective Disorders

Volumn 149, Issue 1-3, 2013, Pages 196-201

  Tohen, M ^a   Katagiri, H ^b   Fujikoshi, S ^b   Kanba, S ^c  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Bipolar; Core symptoms; Depression; Melancholic; Olanzapine monotherapy

Indexed keywords

OLANZAPINE; PLACEBO;

ADULT; AGED; ARTICLE; BIPOLAR I DISORDER; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LASSITUDE; MAJOR CLINICAL STUDY; MALE; MARDS 6 SCORE; MELANCHOLIA; MENTAL PATIENT; MONOTHERAPY; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTICENTER STUDY; PESSIMISM; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCORING SYSTEM; SUICIDAL BEHAVIOR; TREATMENT DURATION; TREATMENT RESPONSE; YOUNG MANIA RATING SCALE;

ACUTE DISEASE; ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84878501728     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.01.022     Document Type: Article

References (19)

1. American Psychiatric Association. 2012. Mixed features specifier. [online] 〈http://www.dsm5.org/ProposedRevisions/pages/proposedrevision. aspx?rid=483#〉.
2. M. Bauer, P. Ritter, H. Grunze, and A. Pfennig Treatment options for acute depression in bipolar disorder Bipolar Disorders 14 Suppl 2 2012 37 50
3. P. Bech, P. Tanghøj, H.F. Andersen, and K. Overø Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression Psychopharmacology (Berlin) 163 2002 20 25
4. F. Benazzi, M. Berk, M.A. Frye, W. Wang, A. Barraco, and M. Tohen Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis Journal of Clinical Psychiatry 70 2009 1424 1431
5. J.R. Calabrese, P.E. Keck Jr., W. Macfadden, M. Minkwitz, T.A. Ketter, R.H. Weisler, A.J. Cutler, R. McCoy, E. Wilson, and J. Mullen A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression American Journal of Psychiatry 162 2005 1351 1360
6. J.F. Goldberg, J.L. Garno, A.C. Leon, J.H. Kocsis, and L. Portera Association of recurrent suicidal ideation with nonremission from acute mixed mania American Journal of Psychiatry 155 1998 1753 1755
7. J.F. Goldberg, R.H. Perlis, C.L. Bowden, M.E. Thase, D.J. Miklowitz, L.B. Marangell, J.R. Calabrese, A.A. Nierenberg, and G.S. Sachs Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD American Journal of Psychiatry 166 2009 173 181
8. J.T. Kantrowitz, and L. Citrome Olanzapine: review of safety 2008 Expert Opinion on Drug Safety 7 2008 761 769
9. D.Z. Lieberman, and F.K. Goodwin Use of olanzapine in the treatment of bipolar I disorder Expert Review of Neurotherapeutics 4 2004 759 767
10. K.R. Merikangas, R. Jin, J.P. He, R.C. Kessler, S. Lee, N.A. Sampson, M.C. Viana, L.H. Andrade, C. Hu, E.G. Karam, M. Ladea, M.E. Medina-Mora, Y. Ono, J. Posada-Villa, R. Sagar, J.E. Wells, and Z. Zarkov Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative Archives of General Psychiatry 68 2011 241 251
11. R.H. Perlis, M.J. Ostacher, J.K. Patel, L.B. Marangell, H. Zhang, S.R. Wisniewski, T.A. Ketter, D.J. Miklowitz, M.W. Otto, L. Gyulai, N.A. Reilly-Harrington, A.A. Nierenberg, G.S. Sachs, and M.E. Thase Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) American Journal of Psychiatry 163 2006 217 224
12. A. Quante, S. Zeugmann, A. Luborzewski, N. Schommer, J. Langosch, C. Born, I. Anghelescu, and J. Wolf Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study Human Psychopharmacology 25 2010 126 132
13. G.S. Sachs, K.S. Ice, P.B. Chappell, J.H. Schwartz, O. Gurtovaya, D.G. Vanderburg, and B. Kasuba Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial Journal of Clinical Psychiatry 72 2011 1413 1422
14. M.E. Thase, C.L. Bowden, M. Nashat, J.M. Eudicone, R. Marcus, R.D. McQuade, and B.X. Carlson Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms International Journal of Psychiatry in Clinical Practice 16 2012 121 131
15. M.E. Thase, W. Macfadden, R.H. Weisler, W. Chang, B. Paulsson, A. Khan, J.R. Calabrese, and BOLDER II Study Group Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study) Journal of Clinical Psychopharmacology 26 2006 600 609
16. M. Tohen, C.L. Bowden, J.R. Calabrese, D. Lin, T.D. Forrester, G.S. Sachs, A. Koukopoulos, L. Yatham, and H. Grunze Influence of sub-syndromal symptoms after remission from manic or mixed episodes British Journal of Psychiatry 189 2006 515 519
17. M. Tohen, D.P. McDonnell, M. Case, S. Kanba, K. Ha, Y.R. Fang, H. Katagiri, and J.C. Gomez Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression British Journal of Psychiatry 201 2012 376 382
18. M. Tohen, E. Vieta, J. Calabrese, T.A. Ketter, G. Sachs, C. Bowden, P.B. Mitchell, F. Centorrino, R. Risser, R.W. Baker, A.R. Evans, K. Beymer, S. Dube, G.D. Tollefson, and A. Breier Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression Archives of General Psychiatry 60 2003 1079 1088
19. L.N. Yatham A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder Journal of Affective Disorders 128 Suppl 1 2011 S21 S28